Skip to main content

Table 2 Impact of the prehabilitation program on nutritional parameters

From: Impact of prehabilitation during neoadjuvant chemotherapy and interval cytoreductive surgery on ovarian cancer patients: a pilot study

  Control group (n = 15) Prehabilitation group (n = 14) p-value
Preoperative HbA1c (%) 5.6 ± 0.6 5.8 ± 0.6 0.382
Intraoperative glucose (BMTest) (mg/dl) 162.7 ± 38.0 154.7 ± 53.5 0.668
Postoperative insulin requirement, n (%) 5 (33.3%) 4 (28.6%) 0.782
Diagnosis Total protein (g/dl) 6.7 ± 0.7 6.8 ± 0.4 0.510
Albumin (g/dl) 3.9 ± 0.5 3.9 ± 0.4 0.959
Prealbumin (mg/dl) 15.6 ± 6.2 14.2 ± 6.6 0.683
Hemoglobin (g/dl) 12.0 ± 1.8 12.2 ± 1.6 0.843
Preoperative Total protein (g/dl) 6.8 ± 0.5 7.4 ± 0.3 0.004
Albumin (g/dl) 4.1 ± 0.5 4.4 ± 0.3 0.209
Prealbumin (mg/dl) 20.2 ± 4.9 22.4 ± 4.3 0.428
Hemoglobin (g/dl) 10.8 ± 1.0 10.8 ± 0.9 0.915
Postoperative Total protein (g/dl) 4.3 ± 0.7 4.9 ± 0.6 0.005
Albumin (g/dl) 2.4 ± 0.6 2.8 ± 0.4 0.021
Prealbumin (mg/dl) 9.5 ± 3.3 12.5 ± 4.3 0.124
Hemoglobin (g/dl) 9.5 ± 1.0 8.9 ± 1.3 0.164
One month postoperative Total protein (g/dl) 7.0 ± 0.7 7.2 ± 0.5 0.693
Albumin (g/dl) 4.2 ± 0.5 4.2 ± 0.4 0.985
Prealbumin (mg/dl) 20.7 ± 8.2 22.2 ± 5.3 0.465
Hemoglobin (g/dl) 11.2 ± 1.0 11.2 ± 1.4 0.683
  1. Data are presented as mean ± SD, unless otherwise specified